המוסול B0

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

CALCIUM CHLORIDE DIHYDRATE; LACTIC ACID; MAGNESIUM CHLORIDE HEXAHYDRATE; SODIUM CARBONATE HYDROGEN; SODIUM CHLORIDE

Disponible depuis:

BAXTER HEALTHCARE DISTRIBUTION LTD., ISRAEL

Code ATC:

B05XA30

forme pharmaceutique:

תמיסה להמופילטרציה

Composition:

CALCIUM CHLORIDE DIHYDRATE 5.145 G / 1000 ML; MAGNESIUM CHLORIDE HEXAHYDRATE 2.033 G / 1000 ML; LACTIC ACID 5.400 G / 1000 ML; SODIUM CHLORIDE 6.45 G / 1000 ML; SODIUM CARBONATE HYDROGEN 3.090 G / 1000 ML

Mode d'administration:

לשימוש עם מכשירי המודיאליזה

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

BIEFFE MEDITAL S.P.A., ITALY

Groupe thérapeutique:

COMBINATIONS OF ELECTROLYTES

Domaine thérapeutique:

COMBINATIONS OF ELECTROLYTES

indications thérapeutiques:

As substitution solution in continuous haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis for acute renal failure.

Date de l'autorisation:

2013-10-31